A Long Term Follow-up Study of TScan TCR-T Products

Recruiting now

Conditions studied: AML, ALL, MDS

In brief

The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored for 15 years from the date of TCR-T cell therapy administration to assess long-term safety and efficacy.

Key facts

Study ID

NCT06976736

Run by

TScan Therapeutics, Inc.

People needed

1000

Starts

2025-09-09

Expected to finish

2040-09-01

Last updated by the study team

2025-09-10

Who can join

Age: 18 and older, up to 110. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants who received a TCR-T cellular therapy in a clinical study sponsored by TScan Therapeutics.
• Signed informed consent.

You may not qualify if…

• None

Where it is running

• City of Hope — Duarte, California, United States (enrolling)
• Mount Sinai — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.